GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ToolGen Inc (XKRX:199800) » Definitions » Equity-to-Asset

ToolGen (XKRX:199800) Equity-to-Asset : 0.32 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is ToolGen Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. ToolGen's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩30,095 Mil. ToolGen's Total Assets for the quarter that ended in Dec. 2023 was ₩93,451 Mil. Therefore, ToolGen's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.32.

The historical rank and industry rank for ToolGen's Equity-to-Asset or its related term are showing as below:

XKRX:199800' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32   Med: 0.91   Max: 0.97
Current: 0.32

During the past 10 years, the highest Equity to Asset Ratio of ToolGen was 0.97. The lowest was 0.32. And the median was 0.91.

XKRX:199800's Equity-to-Asset is ranked worse than
75.08% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs XKRX:199800: 0.32

ToolGen Equity-to-Asset Historical Data

The historical data trend for ToolGen's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ToolGen Equity-to-Asset Chart

ToolGen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.92 0.97 0.93 0.32

ToolGen Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.96 0.96 0.96 0.32

Competitive Comparison of ToolGen's Equity-to-Asset

For the Biotechnology subindustry, ToolGen's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ToolGen's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ToolGen's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where ToolGen's Equity-to-Asset falls into.



ToolGen Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

ToolGen's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=30094.561/93450.754
=0.32

ToolGen's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=30094.561/93450.754
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ToolGen  (XKRX:199800) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


ToolGen Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of ToolGen's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


ToolGen (XKRX:199800) Business Description

Traded in Other Exchanges
N/A
Address
KOR-collar Gasan Digital Valley 1 to 219 digital Byeoksan, 6th 1204 No. ENG No. 1204, Byucksan Digital Valley 6-cha, 219 Gasan Digital 1-ro, Geumcheon-gu, Seoul, KOR
ToolGen Inc is a biotechnology company, which focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments. The company also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services.

ToolGen (XKRX:199800) Headlines

No Headlines